Preservatives News and Research

RSS

5-year-old British autistic boy dies after alternative therapy in U.S.

A 5-year-old British autistic boy has died after undergoing a controversial form of alternative therapy.

29 Aug 2005

Final tests negative for mad cow disease in the U.S.

The U.S. Department of Agriculture's (USDA) National Veterinary Services Laboratories (NVSL) in Ames, Iowa, has determined that the non-definitive test result reported on July 27 is negative for BSE. Tests conducted by the Veterinary Laboratories Agency in Weybridge, England, are also negative for BSE.

4 Aug 2005

Steady upward climb in child vaccinations

According to U.S. health officials, a record high rate of 81 percent of toddlers 19 months to 3 years old are now getting vaccinated with the full recommended series.

27 Jul 2005

Debate on autism link to vaccines fired up again

In a relatively unusual event, federal health officials called a news conference this week in an attempt to affirm the safety of vaccines.

21 Jul 2005

Intestinal hormone secretin should not be used to treat autism

The intestinal hormone secretin, considered by some to be a promising drug in the treatment of autism, does not improve the symptoms and should not be used to treat the disorder, according to a new review of studies.

19 Jul 2005

ID Biomedical's flu vaccine granted fast track status

ID Biomedical Corporation announced today it has been advised by the United States Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) that the Company's Influenza Virus Vaccine (Fluviral) has been granted a Fast Track designation.

13 Jul 2005

Curcumin has potent anticancer powers

Curcumin, a spice commonly used in curries and other south Asian cooking, blocks a key biological pathway needed for development of melanoma and other cancers, say researchers from the University of Texas M. D. Anderson Cancer Center.

12 Jul 2005

ID Biomedical pursues accelerated approval of influenza vaccine

ID Biomedical Corporation announced today that it has been advised by the United States Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) that the Company's injectable influenza vaccine is eligible for accelerated approval and priority review mechanisms, allowing possible licensure of the vaccine in time to manufacture product for the 2006/07 season.

15 Mar 2005

New flu vaccine for kids hits the market

A new pediatric influenza vaccine that contains no preservatives - the only influenza vaccine approved for use in children 6 to 35 months of age - has been produced by the sanofi-aventis Group, in time for the 2005-2006 influenza season.

10 Mar 2005

Merck may have known the overuse of mercury in their vaccines posed a dangerous health threat to children

A Los Angeles Times article today reports that Merck, a leading manufacturer of prescription drugs, knew the overuse of mercury in their vaccines posed a dangerous health threat to children.

8 Feb 2005

Indian curry may be the next Alzheimer's weapon

A dietary staple of India, where Alzheimer's disease rates are reportedly among the world's lowest, holds potential as a weapon in the fight against the disease.

28 Dec 2004

Study on methylisothiazolinone in shampoo lacks a credible scientific basis

Consumers can rest assured that their cosmetic products, including shampoos, are safe. The abstract on Methylisothiazolinone (MI), presented at the Cell Biology 2004 meeting of the American Society for Cell Biology, lacks a credible scientific basis in suggesting that MI could be a safety issue for consumers using personal care products.

6 Dec 2004